Publikationen in Zusammenarbeit mit Forschern von Ikerbasque, Fundación Vasca para la Ciencia (5)

2024

  1. Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta

    Biomedicine and Pharmacotherapy, Vol. 175

2022

  1. E2f2 attenuates apoptosis of activated t lymphocytes and protects from immune‐mediated injury through repression of fas and fasl

    International Journal of Molecular Sciences, Vol. 23, Núm. 1

2019

  1. Hereditary tyrosinemia type I-associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rate

    Journal of Biological Chemistry, Vol. 294, Núm. 35, pp. 13051-13060

2018

  1. Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria

    Science Translational Medicine, Vol. 10, Núm. 459

2016

  1. Stratification and therapeutic potential of PML in metastatic breast cancer

    Nature Communications, Vol. 7